» Articles » PMID: 1311488

Construction of a Genetically Defined Salmonella Typhi Ty2 AroA, AroC Mutant for the Engineering of a Candidate Oral Typhoid-tetanus Vaccine

Overview
Journal Vaccine
Date 1992 Jan 1
PMID 1311488
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The construction of a Salmonella typhi Ty2 strain harbouring defined deletions in both the aroA and aroC genes is described. These deletions have been fully defined at the molecular level by DNA sequencing and have been introduced in such a way that no foreign DNA remains in the S. typhi genome. This strain is attenuated in mice when given by the intraperitoneal route suspended in hog gastric mucin and is attenuated to a similar level to strains harbouring deletions in aroA or aroC alone indicating that both lesions are capable of attenuating independently. We have used this defined S. typhi aroA aroC strain to express stably a non-toxic 50 kDa fragment of tetanus toxin (fragment C) from a gene incorporated into the chromosome. This strain has the advantage of harbouring no antibiotic-resistance markers and we consider it to be a candidate bivalent oral typhoid-tetanus vaccine.

Citing Articles

Vaccines against gastroenteritis, current progress and challenges.

Seo H, Duan Q, Zhang W Gut Microbes. 2020; 11(6):1486-1517.

PMID: 32552414 PMC: 7524147. DOI: 10.1080/19490976.2020.1770666.


Conversion of RpoS Attenuated Serovar Typhi Vaccine Strains to RpoS Improves Their Resistance to Host Defense Barriers.

Burda W, Brenneman K, Gonzales A, Curtiss 3rd R mSphere. 2018; 3(1).

PMID: 29507892 PMC: 5830471. DOI: 10.1128/mSphere.00006-18.


Impact of homologous and non-homologous recombination in the genomic evolution of Escherichia coli.

Didelot X, Meric G, Falush D, Darling A BMC Genomics. 2012; 13:256.

PMID: 22712577 PMC: 3505186. DOI: 10.1186/1471-2164-13-256.


Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Shi H, Santander J, Brenneman K, Wanda S, Wang S, Senechal P PLoS One. 2010; 5(6):e11142.

PMID: 20585446 PMC: 2887840. DOI: 10.1371/journal.pone.0011142.


Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.

Qazi O, Sesardic D, Tierney R, Soderback Z, Crane D, Bolgiano B Infect Immun. 2006; 74(8):4884-91.

PMID: 16861677 PMC: 1539629. DOI: 10.1128/IAI.00500-06.